| Literature DB >> 34080350 |
Alessia Azzu1, Marco Morosin2, Alexios S Antonopoulos2, Massimo Capoccia2, Ulrich Rosendahl2, Raad Mohiaddin2.
Abstract
BACKGROUND: Post-pericardiectomy right ventricular (RV) failure has been reported but it remains not well-studied. To investigate imaging parameters that could predict RV function and the outcome of patients post-pericardiectomy.Entities:
Keywords: Constrictive pericarditis; Echocardiography; Magnetic resonance; Multislice computed tomography; Pericardiectomy
Year: 2021 PMID: 34080350 PMCID: PMC8592688 DOI: 10.4250/jcvi.2020.0223
Source DB: PubMed Journal: J Cardiovasc Imaging
Figure 1Representative examples of cardiac computed tomography images with (A) thickened and calcified pericardium; (B) thickened but not calcified pericardium. Representative examples of CMR images showing positive (C) pericardial T2-STIR images and (D) pericardial late-gadolinium enhancement. Trans-axial slices from turbo spin echo CMR showing thick (E) compared to thin (F) epicardial fat pad (shaded in yellow).
CMR: cardiac magnetic resonance, echo: echocardiographic, T2-STIR: T2 weighted short tau inversion recovery.
Demographic characteristics
| Characteristics | Value | ||
|---|---|---|---|
| Study population | 53 | ||
| Age (years) | 61.2 ± 14.8 | ||
| Weight (kg) | 87.8 ± 28.0 | ||
| Height (cm) | 160.6 ± 38.0 | ||
| BSA (m2) | 1.96 ± 0.27 | ||
| BMI (kg/m2) | 28.23 ± 4.70 | ||
| Previous medical history | |||
| Pericarditis | 2 (3.8) | ||
| Cardiothoracic surgery | 6 (11.3) | ||
| Tuberculosis | 7 (13.2) | ||
| Radiation | 1 (1.9) | ||
| Autoimmune disease | 4 (7.5) | ||
| Asbestosis | 5 (9.4) | ||
| Malignancy | 1 (1.9) | ||
| Unknown | 27 (50.9) | ||
| Postoperative period | |||
| Length of hospital stay (days) | 16.3 ± 18.8 | ||
| Inotropic support (hours) | 107.4 ± 190.8 | ||
| Death | 7 (13.2) | ||
| MOF | 3 | ||
| Bowel ischaemia | 2 | ||
| Mech. complications/bleeding | 2 | ||
| Pericardial imaging | |||
| Pericardial thickness (mm) | 7.38 ± 4.41 | ||
| Epicardial fat thickness (mm) | 5.91 ± 2.70 | ||
| CT calcification (%) | 10 ± 35.7 | ||
| CMR (pre-operative) | |||
| LVEDV (mL) | 106.71 ± 43.94 | ||
| LVESV (mL) | 44.86 ± 25.48 | ||
| LVSV (mL) | 62.00 ± 21.22 | ||
| LVEF (%) | 59.67 ± 8.02 | ||
| LV mass (g) | 90.14 ± 30.44 | ||
| RVEDV (mL) | 112.33 ± 46.29 | ||
| RVESV (mL) | 54.90 ± 29.18 | ||
| RVSV (mL) | 57.38 ± 20.04 | ||
| RVEF (%) | 52.67 ± 9.35 | ||
| LAV (mL) | 94.71 ± 43.51 | ||
| RAV (mL) | 85.19 ± 42.13 | ||
| Echocardiography (pre-operative) | |||
| LVEDV (mL) | 71.50 ± 28.20 | ||
| LVEDVI (mL/m2) | 37.12 ± 16.59 | ||
| LVESV (mL) | 29.26 ± 13.89 | ||
| LVESVI (mL/m2) | 15.20 ± 7.53 | ||
| LVEDD (cm) | 4.22 ± 0.61 | ||
| IVS (cm) | 0.91 ± 0.16 | ||
| PW (cm) | 0.86 ± 0.16 | ||
| LVEF (%) | 59.25 ± 6.42 | ||
| LAV (mL) | 65.87 ± 23.74 | ||
| RAV (mL) | 57.58 ± 27.53 | ||
| E/A ratio | 1.91 ± 0.91 | ||
| E′ septal (cm/s) | 0.11 ± 0.04 | ||
| E/E′ septal | 8.04 ± 4.52 | ||
| E′ lateral (cm/s) | 0.11 ± 0.03 | ||
| E/E′ lateral | 8.30 ± 5.49 | ||
| TAPSE (mm) | 16.19 ± 4.08 | ||
| RVEDD (cm) | 3.42 ± 0.71 | ||
| RVEDA (cm2) | 15.84 ± 4.18 | ||
| RVESA (cm2) | 9.46 ± 3.13 | ||
| RVFAC (%) | 40.49 ± 8.83 | ||
Data are expressed as mean ± standard deviation or as number (percentage).
BMI: body mass index, BSA: body surface area, CMR: cardiac magnetic resonance, CT: computed tomography, IVS: interventricular septum, LV: left ventricular, LAV: left atrial volume, LVEDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction, LVEDD: left ventricular end-diastolic diameter, LVEDVI: left ventricular end-diastolic volume index, LVESV: left ventricular end-systolic volume, LVSV: left ventricular stroke volume, MOF: multi-organ failure, PW: posterior wall, RAV: right atrial volume, RVEDA: right ventricular end-diastolic area, RVEDD: right ventricular end-diastolic diameter, RVEDV: right ventricular end-diastolic volume, RVEF: right ventricular ejection fraction, RVESA: right ventricular end-systolic area, RVESV: right ventricular end-systolic volume, RVFAC: right ventricular fractional area change, RVSV: right ventricular stroke volume, TAPSE: tricuspid annular plane systolic excursion.
Figure 2(A) Histological findings of pericardial biopsy and (B) pericardial imaging by CT and CMR in 53 patients with constrictive pericarditis undergoing pericardiectomy. (C) Distribution of pericardial thickness by CT or CMR, and percentage of CP patients with a thickened pericardium. (D) Heatmap for the relationship between cause-specific CP and the prevalence of histological findings.
CMR: cardiac magnetic resonance, CP: constrictive pericarditis, CT: computed tomography, CTD: connective tissue disorder, LGE: late gadolinium enhancement, TB: tubercolosis.
Preoperative characteristics and inotropic support
| Characteristics | Inotropic support | p | ||
|---|---|---|---|---|
| < 48 hours (n = 25) | ≥ 48 hours (n = 28) | |||
| Age (years) | 59.08 ± 17.00 | 63.04 ± 12.62 | 0.337 | |
| BMI (kg/m2) | 28.63 ± 4.35 | 27.85 ± 5.07 | 0.555 | |
| Cardiopulmonary bypass (%) | 5 (21) | 6 (25) | 0.999 | |
| Renal replacement therapy (%) | 0 (0) | 4 (17) | 0.115 | |
| Bleeding (mL) | 864.5 ± 107.1 | 1,242.0 ± 214.1 | 0.146 | |
| CMR (pre-operative) | ||||
| LVEDV (mL) | 115.20 ± 54.23 | 99.00 ± 32.83 | 0.413 | |
| LVESV (mL) | 49.90 ± 31.53 | 40.27 ± 18.85 | 0.401 | |
| LVSV (mL) | 65.30 ± 25.87 | 59.00 ± 16.66 | 0.511 | |
| LVEF (%) | 58.50 ± 8.03 | 60.73 ± 8.25 | 0.539 | |
| LV mass (g) | 97.30 ± 35.09 | 83.64 ± 25.45 | 0.317 | |
| RVEDV (mL) | 132.60 ± 60.84 | 93.91 ± 13.06 | 0.053 | |
| RVESV (mL) | 68.70 ± 36.48 | 42.36 ± 11.93 |
| |
| RVSV (mL) | 63.70 ± 26.92 | 51.64 ± 8.62 | 0.174 | |
| RVEF (%) | 49.60 ± 8.60 | 55.45 ± 9.50 | 0.157 | |
| LAV (mL) | 73.10 ± 25.81 | 114.36 ± 47.90 |
| |
| RAV (mL) | 85.70 ± 42.04 | 84.73 ± 44.26 | 0.959 | |
| Echocardiography (pre-operative) | ||||
| LVEDV (mL) | 75.23 ± 31.89 | 68.49 ± 25.07 | 0.421 | |
| LVEDVI (mL/m2) | 38.93 ± 19.40 | 35.59 ± 14.03 | 0.502 | |
| LVESV (mL) | 31.88 ± 16.17 | 27.15 ± 11.64 | 0.251 | |
| LVESVI (mL/m2) | 16.37 ± 8.75 | 14.22 ± 6.34 | 0.341 | |
| LVEDD (cm) | 4.24 ± 0.61 | 4.21 ± 0.63 | 0.868 | |
| LVESD (cm) | 2.88 ± 0.62 | 2.86 ± 0.56 | 0.887 | |
| LVEF (%) | 57.68 ± 6.39 | 60.58 ± 6.27 | 0.121 | |
| LA volume (mL) | 69.45 ± 27.36 | 62.72 ± 20.08 | 0.337 | |
| RA volume (mL) | 59.81 ± 32.73 | 55.62 ± 22.58 | 0.617 | |
| E/A ratio | 1.75 ± 0.70 | 2.04 ± 1.05 | 0.342 | |
| e′ septal (cm/s) | 0.10 ± 0.04 | 0.12 ± 0.04 | 0.302 | |
| E/e′ septal | 7.97 ± 5.61 | 8.09 ± 3.71 | 0.950 | |
| E′ lateral (cm/s) | 0.12 ± 0.03 | 0.11 ± 0.04 | 0.443 | |
| E/e′ lateral | 6.44 ± 2.80 | 9.79 ± 6.64 | 0.068 | |
| TAPSE (mm) | 16.29 ± 4.33 | 16.12 ± 3.96 | 0.889 | |
| RVEDD (cm) | 3.64 ± 0.62 | 3.21 ± 0.74 |
| |
| RVEDA (cm2) | 16.05 ± 4.69 | 15.66 ± 3.79 | 0.758 | |
| RVESA (cm2) | 9.66 ± 3.31 | 9.29 ± 3.04 | 0.699 | |
| RVFAC (%) | 40.00 ± 7.62 | 40.91 ± 9.88 | 0.733 | |
Data are expressed as mean ± standard deviation or as number (percentage). Statistically significant p-values (< 0.05) are shown in bold fonts.
BMI: body mass index, CMR: cardiac magnetic resonance, LA: left atrium, LAV: left atrial volume, LV: left ventricular, LVEDD: left ventricular end-diastolic diameter, LVEDV: left ventricular end-diastolic volume, LVEDVI: left ventricular end-diastolic volume index, LVEF: left ventricular ejection fraction, LVESD: left ventricular end-systolic diameter, LVESV: left ventricular end-systolic volume, LVESVI: left ventricular end-systolic volume index, LVSV: left ventricular stroke volume, RA: right ventricular, RAV: right atrial volume, RVEDA: right ventricular end-diastolic area, RVEDD: right ventricular end-diastolic diameter, RVEDV: right ventricular end-diastolic volume, RVEF: right ventricular ejection fraction, RVESA: right ventricular end-systolic area, RVESV: right ventricular end-systolic volume, RVFAC: right ventricular fractional area change, RVSV: right ventricular stroke volume, TAPSE: tricuspid annular plane systolic excursion.
Figure 3(A) A pericardial score based on pericardial calcification/thickness and epicardial fat thickness could be used to assess the difficulty of surgical pericardial dissection and to predict the risk for heart failure and prolonged inotropic support postoperatively. (B) Prognostic accuracy of pericardial score to identify patients at risk for prolonged inotropic support (n = 28).
AUC:= area under the curve, CT: computed tomography, RV: right ventricular.
Figure 4RV cavity size and function preoperatively, postoperatively and at 6 months. Data are shown for changes in (A) RVEDD, (B) RVEDA, (C) RVESA, (D) FAC and (E) TAPSE.
FAC: fractional area change, RV: right ventricular, RVEDA: right ventricular end-diastolic area, RVEDD: right ventricular end-diastolic diameter, RVESA: right ventricular end-systolic area, TAPSE: tricuspid annular plane systolic excursion.
*p < 0.05; †p < 0.001; ‡p < 0.0001 vs. baseline.